JP2024534801A5 - - Google Patents
Info
- Publication number
- JP2024534801A5 JP2024534801A5 JP2024510239A JP2024510239A JP2024534801A5 JP 2024534801 A5 JP2024534801 A5 JP 2024534801A5 JP 2024510239 A JP2024510239 A JP 2024510239A JP 2024510239 A JP2024510239 A JP 2024510239A JP 2024534801 A5 JP2024534801 A5 JP 2024534801A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163235543P | 2021-08-20 | 2021-08-20 | |
| US63/235,543 | 2021-08-20 | ||
| US202163289025P | 2021-12-13 | 2021-12-13 | |
| US63/289,025 | 2021-12-13 | ||
| PCT/US2022/040922 WO2023023347A1 (en) | 2021-08-20 | 2022-08-19 | Prodrugs and derivatives of psilocin and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024534801A JP2024534801A (ja) | 2024-09-26 |
| JPWO2023023347A5 JPWO2023023347A5 (https=) | 2025-08-25 |
| JP2024534801A5 true JP2024534801A5 (https=) | 2025-08-25 |
Family
ID=85241100
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024510239A Pending JP2024534801A (ja) | 2021-08-20 | 2022-08-19 | サイロシンのプロドラッグ及び誘導体ならびにその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250011344A1 (https=) |
| EP (1) | EP4387608A4 (https=) |
| JP (1) | JP2024534801A (https=) |
| KR (1) | KR20240065084A (https=) |
| AU (1) | AU2022328556A1 (https=) |
| CA (1) | CA3229591A1 (https=) |
| TW (1) | TW202315863A (https=) |
| WO (1) | WO2023023347A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2632056B (en) * | 2020-08-21 | 2025-04-16 | Compass Pathfinder Ltd | Novel psilocin derivatives having prodrug properties |
| WO2022120181A1 (en) * | 2020-12-03 | 2022-06-09 | Mydecine Innovations Group Inc. | Novel psilocin analog compositions and methods of synthesizing the same |
| CA3225133A1 (en) | 2021-07-07 | 2023-01-12 | Matthew Alexander James Duncton | N,n-dimethyltryptamine and related psychedlics and uses thereof |
| EP4429672A4 (en) | 2021-11-12 | 2025-04-30 | Terran Biosciences Inc. | PSILOCYBIN AND O-ACETYLPSILOCIN, SALTS AND SOLID FORMS THEREOF |
| TW202333668A (zh) | 2021-12-15 | 2023-09-01 | 美商德利克斯醫療公司 | 經苯氧基及苄氧基取代之精神成形素(psychoplastogen)及其用途 |
| WO2023168023A1 (en) | 2022-03-04 | 2023-09-07 | Reset Pharmaceuticals, Inc. | Co-crystals or salts comprising psilocin |
| US12065404B2 (en) | 2022-03-18 | 2024-08-20 | Enveric Biosciences Canada Inc. | C4-carboxylic acid-substituted tryptamine derivatives and methods of using |
| EP4493544A4 (en) * | 2022-03-18 | 2026-03-04 | Enveric Biosciences Canada Inc | TRYPTAMINE DERIVATIVE SALTS SUBSTITUTED WITH C4-CARBOXYLIC ACID AND C4-CARBONOTHIOATE AND METHODS OF USE |
| AU2022446955A1 (en) * | 2022-03-18 | 2024-11-07 | Enveric Biosciences Canada Inc. | C4-carboxylic acid-substituted tryptamine derivatives and methods of using |
| WO2024055106A1 (en) * | 2022-09-12 | 2024-03-21 | Bionxt Solutions Inc. | Amino acid and carbohydrate psilocin derivatives |
| EP4618981A1 (en) | 2022-11-17 | 2025-09-24 | Remedi, Inc. | Combinations of monoamine oxidase inhibitors and serotonin receptor agonists and their therapeutic use |
| US20240269113A1 (en) * | 2023-01-24 | 2024-08-15 | Compass Pathfinder Limited | 3-(2-(DIMETHYLAMINO)ETHYL)-1H-INDOL-4-yl DERIVATIVES |
| US20250066394A1 (en) * | 2023-08-25 | 2025-02-27 | Compass Pathfinder Limited | 3-(2-(DIMETHYLAMINO)ETHYL)-1H-INDOL-4-yl DERIVATIVES |
| EP4592276A1 (en) | 2024-01-29 | 2025-07-30 | Universität Heidelberg | Novel acyloxymethyl prodrugs of psilocin and related 4-hydroxytryptamines obtained by an efficient synthetic approach |
| CN120329323B (zh) * | 2025-04-16 | 2026-01-13 | 黄冈鲁班药业股份有限公司 | 一种头孢吡普酯侧链的制备方法及应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3075992A (en) * | 1958-09-12 | 1963-01-29 | Sandoz Ltd | Esters of indoles |
| US20180021326A1 (en) * | 2016-07-23 | 2018-01-25 | Paul Edward Stamets | Compositions and methods for enhancing neuroregeneration and cognition by combining mushroom extracts containing active ingredients psilocin or psilocybin with erinacines or hericenones enhanced with niacin |
| WO2019099745A1 (en) * | 2017-11-16 | 2019-05-23 | CaaMTech, LLC | Compositions comprising a psilocybin derivative and a cannabinoid |
| PH12022551981A1 (en) * | 2020-02-04 | 2023-10-16 | Mindset Pharma Inc | Psilocin derivatives as serotonergic psychedelic agents for the treatment of cns disorders |
| AU2021268204A1 (en) * | 2020-05-08 | 2022-12-08 | Psilera Inc. | Novel compositions of matter and pharmaceutical compositions |
| CN115867533B (zh) * | 2020-06-30 | 2024-07-23 | 加拿大瑞安神经科学公司 | 色胺前药 |
| GB2632056B (en) * | 2020-08-21 | 2025-04-16 | Compass Pathfinder Ltd | Novel psilocin derivatives having prodrug properties |
| WO2022120181A1 (en) * | 2020-12-03 | 2022-06-09 | Mydecine Innovations Group Inc. | Novel psilocin analog compositions and methods of synthesizing the same |
| MX2023014620A (es) * | 2021-06-09 | 2024-01-30 | Atai Therapeutics Inc | Nuevos profarmacos y conjugados de dimetiltriptamina. |
-
2022
- 2022-08-19 WO PCT/US2022/040922 patent/WO2023023347A1/en not_active Ceased
- 2022-08-19 AU AU2022328556A patent/AU2022328556A1/en active Pending
- 2022-08-19 KR KR1020247008856A patent/KR20240065084A/ko active Pending
- 2022-08-19 TW TW111131397A patent/TW202315863A/zh unknown
- 2022-08-19 US US18/684,970 patent/US20250011344A1/en not_active Abandoned
- 2022-08-19 EP EP22859231.7A patent/EP4387608A4/en active Pending
- 2022-08-19 CA CA3229591A patent/CA3229591A1/en active Pending
- 2022-08-19 JP JP2024510239A patent/JP2024534801A/ja active Pending